Short description
Collegium Pharmaceutical is a specialty pharmaceutical company focused on the development of products for the treatment of chronic pain.
Description
Collegium Pharmaceutical is a specialty pharmaceutical company focused on the development of proprietary, late-stage pharmaceutical products. These products address the growing problems associated with non-medical use and abuse of prescription drugs through formulation based improvements protected by intellectual property (IP). Collegium is focused on building a portfolio of products for the treatment of chronic pain that possess tamper-resistant features and provide extended-release delivery using its patent-protected DETERx formulation platform.
Last funding
Noaccess
Sign in for full access
Total funding
$$121212
Sign in for full access
Location
Stoughton, Massachusetts, United States, North America
Founded on
January 1, 2002
Exited on
May 7, 2015
Went public on
May 7, 2015
Stock symbol
COLL
Non-profit?
No
Acquired?
No
Employees count
101-250
Revenue range
$7890 - 12340
Sign in for full access
Investors
Noaccess, Noaccess, Noaccessforu, Cannot Access, Nopepepe, Noaccess, Noaccess, Nopepepe, Nopepepe, Absolutely Noaccess, Noaccess, Noaccess, Noaccess
Sign in for full access
Founders
Jane Hirsch, Michael T. Heffernan